OS Therapies (OSTX) Stock Price, News & Analysis

Company Overview

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.

Key Stats

• Today's Range: $3.53 to $4.21
• 50-Day Range: $1.74 to $4.71
• 52-Week Range: $1.58 to $6.48
• Volume: 61,426 shs
• Average Volume: 130,154 shs
• Market Capitalization: $84.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Strong Buy

OSTX Stock Analysis - Frequently Asked Questions

How have OSTX shares performed this year?

OS Therapies' stock was trading at $4.00 at the beginning of 2024. Since then, OSTX stock has decreased by 0.7% and is now trading at $3.97.
View the best growth stocks for 2024 here.

When did OS Therapies IPO?

OS Therapies (OSTX) raised $8 million in an initial public offering (IPO) on Thursday, August 1st 2024. The company issued 2,000,000 shares at $4.00 per share. Brookline Capital Markets (Division of Arcadia Securities LLC) acted as the underwriter for the IPO.

When does OS Therapies' lock-up period expire?

OS Therapies' lock-up period expires on Tuesday, January 28th. OS Therapies had issued 1,600,000 shares in its public offering on August 1st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Who are OS Therapies' major shareholders?

OS Therapies' top institutional investors include Virtu Financial LLC (0.05%).

How do I buy shares of OS Therapies?

Shares of OSTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of OS Therapies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that OS Therapies investors own include AST SpaceMobile (ASTS), Energy Transfer (ET), Black Stone Minerals (BSM), Kinder Morgan (KMI), Main Street Capital (MAIN), Atlas Energy Solutions (AESI) and Chevron (CVX).

Company Calendar

• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NYSE:OSTX
• Previous Symbol: NYSE:OSTX
• CUSIP: N/A
• CIK: 1795091
• Web: N/A
• Phone: (410) 297-7793
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $8.00
• High Stock Price Target: $8.00
• Low Stock Price Target: $8.00
• Potential Upside/Downside: +101.5%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,790,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -569.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.76
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 21,238,000
• Free Float: N/A
• Market Cap: $84.31 million
• Optionable: N/A
• Beta: N/A